EUVIMEDEUVIMED entdecken
Crossref

Evaluation of Phenobarbital Serum Levels on Clinical Outcomes for the Treatment of Severe Alcohol Withdrawal Syndrome in a Medical Intensive Care Unit

Moqadam S Rhamatzada, Krislyn A Schweiger, Paul H Mayo, Zubair M Hasan, Mangala Narasimhan, Joanna S Fishbein, Keith P Falsetta iD

Journal of Pharmacy Practice · 13.05.2026

DOI: 10.1177/08971900261450711 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy Practice, online erschienen am 13.05.2026. Verfasst von Moqadam S Rhamatzada und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Services, Long Island Jewish Medical Center, Northwell Health, New Hyde Park, NY, USA. Die Arbeit nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Optimal phenobarbital serum levels for treating severe alcohol withdrawal syndrome (AWS) remain unclear.

Objective

This study evaluated whether phenobarbital serum levels are associated with symptom control in patients with severe AWS admitted to a medical intensive care unit (MICU).

Methods

We conducted a single-center, retrospective analysis of adult MICU patients treated with phenobarbital for severe AWS between January 2011 and December 2022. Patients were categorized into two cohorts based on symptom control status: (1) symptom controlled and (2) non-symptom controlled. The primary objective was to assess the relationship between phenobarbital serum levels and symptom control. Secondary objectives evaluated dosing regimens and safety outcomes.

Results

Of 114 patients (63 symptom controlled, 51 non-symptom controlled), no significant association was found between phenobarbital levels (32.2 ± 19.9 vs 36.9 ± 16.0 mcg/mL) (mean, SD) and symptom control ( P = 0.08). Phenobarbital dosing regimen, loading dose (LD) ± as needed (PRN) doses (n = 49) vs PRN only (n = 65), was not significantly associated with MICU LOS ( P = 0.09). However, treatment duration was shorter in the PRN only group (median 54 vs 97 hours; P = 0.016). Endotracheal intubation and vasopressor use were more common in non-symptom controlled patients. No mortality occurred in either group.

Conclusion

No significant evidence was found to suggest that phenobarbital serum levels were associated with symptom control in patients admitted to a MICU for severe AWS as defined in this study.

Schlagwörter

Stichwörter der Autor:innen

alcohol withdrawalintensive carephenobarbitalserum levelsymptom control

Autor:innen und Institutionen

  • Department of Pharmacy Services, Long Island Jewish Medical Center, Northwell Health, New Hyde Park, NY, USA.
  • Division of Pulmonary, Critical Care, and Sleep Medicine, Long Island Jewish Medical Center, Northwell Health, New Hyde Park, NY, USA.
  • Division of Pulmonary, Critical Care, and Sleep Medicine, Northshore University Medical Center, Northwell Health, Manhasset, NY, USA.
  • Medical Intensive Care Unit, Long Island Jewish Medical Center, Northwell Health, New Hyde Park, NY, USA.
  • SVP, Critical Care Services, Medical Director of the Acute Lung Injury/VV ECMO Program, Northwell Health, New Hyde Park, NY, USA.
  • Office of Academic Affairs, Northwell Health, New Hyde Park, NY, USA.

ORCID-Profile: Keith P Falsetta

Zitieren

APA

Rhamatzada, M. S., Schweiger, K. A., Mayo, P. H., Hasan, Z. M., Narasimhan, M., Fishbein, J. S., & Falsetta, K. P. (2026). Evaluation of Phenobarbital Serum Levels on Clinical Outcomes for the Treatment of Severe Alcohol Withdrawal Syndrome in a Medical Intensive Care Unit. Journal of Pharmacy Practice. https://doi.org/10.1177/08971900261450711

Vancouver

Rhamatzada MS, Schweiger KA, Mayo PH, Hasan ZM, Narasimhan M, Fishbein JS, et al. Evaluation of Phenobarbital Serum Levels on Clinical Outcomes for the Treatment of Severe Alcohol Withdrawal Syndrome in a Medical Intensive Care Unit. Journal of Pharmacy Practice. 2026. doi:10.1177/08971900261450711

BibTeX
@article{Rhamatzada2026,
  author = {Rhamatzada, Moqadam S and Schweiger, Krislyn A and Mayo, Paul H and Hasan, Zubair M and Narasimhan, Mangala and Fishbein, Joanna S and Falsetta, Keith P},
  title = {Evaluation of Phenobarbital Serum Levels on Clinical Outcomes for the Treatment of Severe Alcohol Withdrawal Syndrome in a Medical Intensive Care Unit},
  journal = {Journal of Pharmacy Practice},
  year = {2026},
  doi = {10.1177/08971900261450711}
}
Kostenlos starten →